Mohammad-Ali Ghaffari
Overview
Explore the profile of Mohammad-Ali Ghaffari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karimi M, Babaahmadi-Rezaei H, Mohammadzadeh G, Ghaffari M
Iran J Pathol
. 2018 Mar;
12(2):135-143.
PMID: 29515635
Background And Objective: According to reports, a serine protease inhibitor (Maspin) suppresses metastasis, invasion and angiogenesis in breast and prostate cancers. Silibinin is a natural polyphenolic flavonoid with anti-cancer activity....
2.
Sharifat N, Zadeh G, Ghaffari M, Dayati P, Kamato D, Little P, et al.
J Pharm Pharmacol
. 2016 Dec;
69(1):66-72.
PMID: 27905105
Objective: G protein-coupled receptor (GPCR) agonists through their receptors can transactivate protein tyrosine kinase receptors such as epidermal growth factor receptor and serine/threonine kinase receptors most notably transforming growth factor...
3.
Mohammadzadeh G, Ghaffari M, Bazyar M, Kheirollah A
Adv Biomed Res
. 2016 Mar;
5:27.
PMID: 27014654
Background: Variations in the hepatic lipase (HL) gene are the potential candidate for coronary artery disease (CAD) especially in type 2 diabetes mellitus (T2DM) in diverse populations. We assessed the...
4.
Mohammadzadeh G, Ghaffari M, Heibar H, Bazyar M
Iran Biomed J
. 2016 Jan;
20(3):152-60.
PMID: 26781170
Background: Adiponectin, an adipocyte-secreted hormone, is known to have anti-atherogenic, anti-inflammatory, and anti-diabetic properties. In the present study, the association between two common single nucleotide polymorphisms (SNPs) (+45T/G and +276G/T)...
5.
Mohammadzadeh G, Ghaffari M, Bafandeh A, Hosseini S, Ahmadi B
Iran J Cancer Prev
. 2015 May;
8(2):100-8.
PMID: 25960849
Background: Potential association of leptin (LEP) gene polymorphisms has been suggested in the processes leading to breast cancer initiation and progression. We investigated whether genetic variations in the LEP -2548G/A...
6.
Mohammadzadeh G, Ghaffari M, Bafandeh A, Hosseini S
Iran J Basic Med Sci
. 2014 Nov;
17(8):588-94.
PMID: 25422752
Objectives: Leptin receptor (LEPR) is a member of the class I cytokine receptor super-family that is known implicated in the initiation and progression of breast cancer. We have investigated the...
7.
Mohammadzadeh G, Ghaffari M, Bafandeh A, Hosseini S
J Res Med Sci
. 2014 Aug;
19(5):433-8.
PMID: 25097626
Background: Leptin plays a key role in the regulation of energy expenditure and is known to circulate in both free and bound forms. Soluble leptin receptor (sOB-R) is a unique...
8.
Mohammadzadeh G, Ghaffari M
Iran Red Crescent Med J
. 2014 Apr;
16(1):e8742.
PMID: 24719717
Background: Adiponectin, an adipocyte-derived hormone, is implicated in diabetes mellitus type 2 and atherosclerosis. The study was designed to investigate whether serum adiponectin levels in patients with both coronary artery...